Xenon Pharmaceuticals (XENE) Other Gross PP&E Adjustments (2016 - 2025)
Xenon Pharmaceuticals (XENE) has disclosed Other Gross PP&E Adjustments for 13 consecutive years, with -$8.1 million as the latest value for Q4 2025.
- Quarterly Other Gross PP&E Adjustments fell 15.8% to -$8.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$8.1 million through Dec 2025, down 15.8% year-over-year, with the annual reading at -$8.1 million for FY2025, 15.8% down from the prior year.
- Other Gross PP&E Adjustments for Q4 2025 was -$8.1 million at Xenon Pharmaceuticals, up from -$9.5 million in the prior quarter.
- The five-year high for Other Gross PP&E Adjustments was -$1.6 million in Q4 2021, with the low at -$10.9 million in Q1 2023.
- Average Other Gross PP&E Adjustments over 5 years is -$7.8 million, with a median of -$8.6 million recorded in 2022.
- The sharpest move saw Other Gross PP&E Adjustments tumbled 559.57% in 2022, then soared 63.37% in 2023.
- Over 5 years, Other Gross PP&E Adjustments stood at -$1.6 million in 2021, then crashed by 559.57% to -$10.7 million in 2022, then skyrocketed by 63.37% to -$3.9 million in 2023, then tumbled by 77.72% to -$7.0 million in 2024, then dropped by 15.8% to -$8.1 million in 2025.
- According to Business Quant data, Other Gross PP&E Adjustments over the past three periods came in at -$8.1 million, -$9.5 million, and -$8.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.